Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q92340983 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010745.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q92340983 | ||
| 024 | ‡a 0000-0002-4524-9892 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q92340983 | ||
| 100 | 0 | ‡a Nynke G L Jager ‡c researcher (ORCID 0000-0002-4524-9892) ‡9 en | |
| 400 | 0 | ‡a Nynke G L Jager ‡c wetenschapper ‡9 nl | |
| 670 | ‡a Author's Antibiotic exposure at the site of infection: principles and assessment of tissue penetration | ||
| 909 | ‡a (orcid) 0000000245249892 ‡9 1 | ||
| 919 | ‡a antibioticexposureatthesiteofinfectionprinciplesandassessmentoftissuepenetration ‡A Antibiotic exposure at the site of infection: principles and assessment of tissue penetration ‡9 1 | ||
| 996 | ‡2 NTA|287752291 | ||
| 996 | ‡2 ISNI|0000000397174869 | ||
| 996 | ‡2 NTA|153287071 | ||
| 996 | ‡2 NTA|434009946 | ||
| 996 | ‡2 ISNI|000000004160360X | ||
| 996 | ‡2 NTA|383817412 | ||
| 996 | ‡2 ISNI|0000000390235358 | ||
| 996 | ‡2 NTA|160886546 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 |
